This bill amends Section 50-32-232 of the Montana Code Annotated (MCA) to revise the list of specific dangerous drugs included in Schedule V controlled substances. A significant change is the addition of gabapentin, also known as 1-(aminomethyl)cyclohexaneacetic acid, to the list of depressants. The bill also clarifies that gabapentin will be included alongside other substances such as lacosamide and pregabalin, which are already recognized as depressants affecting the central nervous system.

Additionally, the bill removes the word "and" from the list of depressants before the mention of gabapentin, indicating a structural change in the legal language. This legislative action reflects an effort to regulate gabapentin more closely due to its potential for misuse and aligns with the state's ongoing efforts to manage controlled substances effectively.

Statutes affected:
LC Text: 50-32-232
HB0041_1(1): 50-32-232
HB0041_1(2): 50-32-232
HB0041_1(3): 50-32-232
HB0041_1(4): 50-32-232
HB0041_1(5): 50-32-232
HB0041_1(6): 50-32-232
HB0041_1: 50-32-232
HB0041_2(1): 50-32-232
HB0041_2(10): 50-32-232
HB0041_2(11): 50-32-232
HB0041_2(2): 50-32-232
HB0041_2(3): 50-32-232
HB0041_2(4): 50-32-232
HB0041_2(5): 50-32-232
HB0041_2(6): 50-32-232
HB0041_2(7): 50-32-232
HB0041_2(8): 50-32-232
HB0041_2(9): 50-32-232
HB0041_2: 50-32-232
HB0041_X(1): 50-32-232
HB0041_X(2): 50-32-232
HB0041_X(3): 50-32-232
HB0041_X(4): 50-32-232
HB0041_X(5): 50-32-232
HB0041_X(6): 50-32-232
HB0041_X(7): 50-32-232
HB0041_X(8): 50-32-232
HB0041_X: 50-32-232